Literature DB >> 31771494

[HIV in Sub-Saharan Africa: Where Are We Today?]

Anna Eichenberger1,2,3, Maja Weisser1,2,3,4, Manuel Battegay4.   

Abstract

HIV in Sub-Saharan Africa: Where Are We Today? Abstract. In sub-Saharan Africa the HIV epidemic has changed remarkedly due to expanded testing and easier access to antiretroviral medication. The rate of new infections has decreased substantially since 2005, the life expectancy of people living with HIV has increased and the mortality rate has declined. Yet still a lot needs to be achieved to stop the ongoing epidemic. Women are still at a higher risk to get infected and stigma and discrimination are a hindrance to further reduce the incidence. Challenges like the lack of technical capacities, especially to perform viral load and resistance testing, refusal of testing or condom use and increasing drug resistance to first-line therapies jeopardize the goal of 90-90-90: 90 % of people tested, 90 % of positives under care and 90 % of treated persons virologically controlled. New testing strategies and medication with higher efficacies which, when taken regularly, stop the transmission completely, provide hope in the fight against HIV.

Entities:  

Keywords:  90–90–90; HIV/AIDS; Prävention; Subsahara-Afrika; VIH/SIDA; antiretroviral therapy; antiretrovirale Therapie; l’Afrique subsaharienne; prevention; prévention; sub-Saharan Africa; traitement antirétroviral

Mesh:

Substances:

Year:  2019        PMID: 31771494     DOI: 10.1024/1661-8157/a003334

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  2 in total

1.  Appreciative inquiry and the co-creation of an evaluation framework for Extension for Community Healthcare Outcomes (ECHO) implementation: a two-country experience.

Authors:  Smita Ghosh; Bruce B Struminger; Neeta Singla; Brenna M Roth; Anil Kumar; Sunil Anand; Emmanuel Mtete; Jacob Lusekelo; Irene Massawe; Elizabeth Jarpe-Ratner; Steven M Seweryn; Kris Risley; Patrick K Moonan; Eve Pinsker
Journal:  Eval Program Plann       Date:  2022-03-10

2.  Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.

Authors:  Nalia Ismael; Eduan Wilkinson; Isabel Mahumane; Hernane Gemusse; Jennifer Giandhari; Adilson Bauhofer; Adolfo Vubil; Pirolita Mambo; Lavanya Singh; Nédio Mabunda; Dulce Bila; Susan Engelbrecht; Eduardo Gudo; Richard Lessells; Túlio de Oliveira
Journal:  Viruses       Date:  2022-09-09       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.